RankAlpha logo
Back to Rankings

AKBA

Akebia TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AKBA vs peer average
38/100
AKBA vs. peer average (D vs. C)
Grade spread
A 1 · C 3 · D 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

XFOR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $348.04M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerXFORX4
AKBA
Akebia Therapeutics
XFOR
X4
Grade
D
D
Momentum
16
24
Value
65
41
Sentiment
-
76
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs XFOR

AKBA / XFOR
Grade Position
Below peers
AKBA vs. peer average (D vs. C)
38/100
Momentum
16
XFOR
Value
65
AKBA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKBA
1
XFOR
X4 Pharmaceuticals Inc Common
D
40/100
Even
2
LAB
Standard BioTools Inc Common
D
40/100
Even
3
ORGO
Organogenesis Holdings Inc Class A Common
D
40/100
Even
4
CUVL
Clinuvel Pharmaceuticals Ltd ADR
D
40/100
Even
5
ZNTL
Zentalis Pharmaceuticals Inc Common
C
60/100
-1
XFOR is the first peer returned for this comparison set.